Legend Biotech Funding: $520M Raised, Series A (2020)

Legend Biotech funding overview

Legend Biotech has raised $520M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in April 2020. The round record for Legend Biotech runs through 2020; nothing later has been disclosed. Investors on record include FMR LLC (Fidelity), Westfield Capital Management Co Lp, BlackRock, Inc., Deerfield Management Company, L.P., The Vanguard Group, State Street Corp. 6 distinct backers are named across the disclosed rounds.

Legend Biotech at a glance

Total raised: $520M
Latest round: Series A
Latest round date: April 2020
Notable investors: FMR LLC (Fidelity), Westfield Capital Management Co Lp, BlackRock, Inc., Deerfield Management Company, L.P., The Vanguard Group, State Street Corp

Frequently asked about Legend Biotech funding

How much has Legend Biotech raised?: Legend Biotech has raised $520M in total disclosed funding across the rounds on record.
Who has invested in Legend Biotech?: FMR LLC (Fidelity), Westfield Capital Management Co Lp, BlackRock, Inc., Deerfield Management Company, L.P., The Vanguard Group, State Street Corp are named among the investors backing Legend Biotech.
What was the latest Legend Biotech funding round?: The most recent disclosed round is a Series A, announced in April 2020.
Where is Legend Biotech based?: No headquarters location is disclosed for Legend Biotech.
When did Legend Biotech last raise?: The last disclosed Legend Biotech round closed in April 2020 at Series A.

Legend Biotech totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.

Legend Biotech Funding: $520M Raised, Series A (2020)

Legend Biotech funding overview

Legend Biotech at a glance

Frequently asked about Legend Biotech funding

Companies related to Legend Biotech (30)

Browse related funding lists (3)